![J. Michael Flinn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
J.
Michael Flinn has been a Director of Access Pharmaceuticals, Inc. since 1983 and is a Director of Lonesome Dove Petroleum, Inc. He was Chairman of Access Pharmaceuticals Board from 2004 to 2006 and a Member of the Compensation Committee.
From 1970 to 2000, Mr. Flinn was an Investment Counselor and a Consultant of the Operations Group for United Asset Management.
He served as a Security Analyst in the area of healthcare and natural resources.
From 1970 to 1995, Mr. Flinn was Principal and Chairman of Sirach Capital Management, Inc.
| Companies | Position | End |
|---|---|---|
Lonesome Dove Petroleum, Inc. | Director/Board Member | 2019-07-17 |
| ABEONA THERAPEUTICS INC. | Chairman | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 2 |
|---|---|
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Lonesome Dove Petroleum, Inc. |
Select your edition
All financial news and data tailored to specific country editions
